Aliquots (0.1mL) of whole-bloodpools preparedto contain variousconcentrations of phenylalaninewere appliedto filter-paper collection cards,dried, and storedinsealedbags. We measured the phenylalanine contentof the driedblood spotsby bioassay, fluorometry, and "high-performance" liquidchromatography,and found thatthe concentrations remained constant for two years when samples were kept at -20 #{176}C or lower. Intra-and interlaboratory studies showed thatresults forphenylalanine were greaterforlaboratories usingbioassayproceduresthanforthose usingfluorometric procedures.Further, CVs (bothamong-and within-laboratory) obtained with fluorometric procedures were nearly half as greatas the CVs obtainedby laboratories usingbioassay techniques.
The inherited metabolic disease phenylketonuria (P1(U) can be readily detected by measuring an increase in phenylalanine (Phe) concentrations in infants' blood. Although some screening laboratories use fluorometric methods (1) to detect PKU, most prefer to use bioassay tests (2), which are inexpensive, easy to perform, and automatable (several hundred specimens can be analyzed within a single run). On the other hand, the fluorometricassays are more quantitative and specific.
Here we compare our results for Phe in dried blood spots collected on filter paper-as examined by bioassay, fluorometric, and "high-performance" liquid-chromatographic methods-with those reported in interlaboratory surveys.
Materials and Methods

Materials
Serum and erythrocytes from A+ blood were obtained from the International Red Cross. The erythrocytes were processed with a plasma extractor, an infusion scale, a plasma-transfer set, and sampling-site coupler (all from Fenwall Laboratories, Morton Grove, IL 60053). Serum was treated with neutral Norit charcoal (Fisher Scientific, Fair Lawn, NJ 07410) and dextran sulfate 500-S (Sigma Chemical Co.,St.Louis,MO 63178). We used a refrigerated RC-2B Sorvall centrifuge (Du Pont, Newton, CA 06470), and sterile filtration equipment from Millipore, Bedford,MA 01730. After adding L-Phe (Sigma Chemical Co.) to whole-blood poolsprepared from treated serum and erythrocytes, we 
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Treated serum. We used charcoal and dextran sulfateto remove endogenous Phe and to partly delipidate serum (3). After being mixed overnight with serum or plasma (4 g of charcoal per 100 mL), most of the charcoal was removed by centrifugation, the last traces of charcoal being removed by filtration through coarse filter paper. Charcoal-treated serum was mixed with 30 mg of dextran sulfate per deciliter of serum for 30 nun and then centrifuged. 
Erythrocytes.
To wash erythrocyte preparations, we inserted a needle from a plasma-transfer set attached to a bag of saline (NaCl, 9 g/L) into a sampling-site coupler attached to a bag containing erythrocytes, and added 200 mL of saline to each container of erythrocytes.
After gently mixing the contents of the bags, we removed the saline by centrifugation. We repeated the saline wash, then transferred the washed cells to 250-mL bottles and centrifuged these at 8000 x g. The buffy coat was removed, and the cells were transferred to a 2-L graduated cylinder.
Dried blood spots. We combined washed erythrocytes with charcoal-treated serum to produce a whole-blood pool with a hematocrit of 55%, then added Phe to various concentrations. After hemolyzing the pools by freezing and thawing, we applied 1-mL aliquots to filter paper cards as described by Hearn and Hannon (4), then stored the dried-blood spot cards in sealed plastic bags containing desiccant packages.
Phenylalanine Analyses
We used three procedures to measure Phe: a bioassay, performed with kits from BBL (2); a fluorometric procedure, Interpolation mathod
In-house (6) 0-39 (2) Other (1) onto a reversed-phase column. Chromatographic conditions and detection were identical to those we have previously described (5).
Interlaboratory Studies
Blood spot specimens, prepared as described, were shipped to PKU screening laboratories, along with handling instructions and a questionnaire-report form, for analysis by each laboratory's routine procedure for Phe. The questionnairereport form requested information on various aspects of the assay: the diameter of the blood spot used for analysis, the Phe content of calibrators, the kinds of methods used to relate calibrator response to concentration, and the laboratory's estimate of the "normal range." This information and the analytical results were returned to the Centers for Disease Control (CDC) for statistical analysis. Other (1 The most striking observation is the difference between the CVs obtained with the two assay methods. In every case both the among-and within-lab CVs were greater for the bioassay.Within-lab CVs for the bioassay were near 15%, as compared with fluorometric CVs ofonly 7% for three of the four specimens. CVs were greatest for specimens containing Phe <20 mg/L.
Results
Discussion
Data in Table 2 show that Phe values are greater when assayed by bioassay procedures than when analyzed fluoro- Our findings on the thermal instability of ifiter paper whole-blood samples (Figure 1) for the most part agree with those previously reported (9, 10). Sumi et al. (11) found that when sample blood spots were stored at 120 #{176}C for 3 mm, Phe contentin the spots decreasedby 20%. 
